Andy hurley named agenus chief commercial officer

Lexington, mass., feb. 09, 2021 (globe newswire) -- agenus inc. (nasdaq: agen), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and infections, today announced the appointment of andy hurley as its chief commercial officer.
AGEN Ratings Summary
AGEN Quant Ranking